Oramed Pharmaceuticals
ORMP
#8967
Rank
NZ$0.23 B
Marketcap
NZ$5.89
Share price
-2.27%
Change (1 day)
44.90%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): NZ$1.44

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$1.39. In 2024 the company made an earnings per share (EPS) of NZ-$0.82 a decrease over its 2023 EPS that were of NZ$0.24.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$1.44-274.7%
2024NZ-$0.82-442.86%
2023NZ$0.24-114.89%
2022NZ-$1.6120.51%
2021NZ-$1.3339.29%
2020NZ-$0.96-31.71%
2019NZ-$1.40-4.65%
2018NZ-$1.478.86%
2017NZ-$1.35-9.2%
2016NZ-$1.4929.85%
2015NZ-$1.158.06%
2014NZ-$1.065.08%
2013NZ-$1.013.51%
2012NZ-$0.98137.5%
2011NZ-$0.41-60%
2010NZ-$1.03-0%
2009NZ-$1.03-16.67%
2008NZ-$1.23-25%
2007NZ-$1.64700%
2006NZ-$0.21303.56%
2005NZ-$0.05089

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ-$10.17-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$6.01 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$6.34 357.49%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
NZ-$0.51-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
NZ-$0.33-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA